245 related articles for article (PubMed ID: 22467334)
21. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
22. Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.
Perrotti D; Silvestri G; Stramucci L; Yu J; Trotta R
Curr Drug Targets; 2017; 18(4):377-388. PubMed ID: 27307150
[TBL] [Abstract][Full Text] [Related]
23. New routes to eradicating chronic myelogenous leukemia stem cells by targeting metabolism.
Naka K
Int J Hematol; 2021 May; 113(5):648-655. PubMed ID: 33666817
[TBL] [Abstract][Full Text] [Related]
24. Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis.
Gu Y; Zheng W; Zhang J; Gan X; Ma X; Meng Z; Chen T; Lu X; Wu Z; Huang W; Xu R
Leukemia; 2016 Jun; 30(6):1282-9. PubMed ID: 27012864
[TBL] [Abstract][Full Text] [Related]
25. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia.
Hurtz C; Hatzi K; Cerchietti L; Braig M; Park E; Kim YM; Herzog S; Ramezani-Rad P; Jumaa H; Müller MC; Hofmann WK; Hochhaus A; Ye BH; Agarwal A; Druker BJ; Shah NP; Melnick AM; Müschen M
J Exp Med; 2011 Oct; 208(11):2163-74. PubMed ID: 21911423
[TBL] [Abstract][Full Text] [Related]
26. Leukemia stem cells: the root of chronic myeloid leukemia.
Zhou H; Xu R
Protein Cell; 2015 Jun; 6(6):403-12. PubMed ID: 25749979
[TBL] [Abstract][Full Text] [Related]
27. Chronic myeloid leukemia blast crisis arises from progenitors.
Michor F
Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
[TBL] [Abstract][Full Text] [Related]
28. An RNA editing fingerprint of cancer stem cell reprogramming.
Crews LA; Jiang Q; Zipeto MA; Lazzari E; Court AC; Ali S; Barrett CL; Frazer KA; Jamieson CH
J Transl Med; 2015 Feb; 13():52. PubMed ID: 25889244
[TBL] [Abstract][Full Text] [Related]
29. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
Clarkson B; Strife A; Wisniewski D; Lambek CL; Liu C
Leukemia; 2003 Jul; 17(7):1211-62. PubMed ID: 12835715
[TBL] [Abstract][Full Text] [Related]
30. CD44: a potential therapeutic target in chronic myeloid leukemia.
Shi R; Liu X
Pharmazie; 2021 Dec; 76(12):574-578. PubMed ID: 34986951
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
[TBL] [Abstract][Full Text] [Related]
32. Critical molecular pathways in cancer stem cells of chronic myeloid leukemia.
Chen Y; Peng C; Sullivan C; Li D; Li S
Leukemia; 2010 Sep; 24(9):1545-54. PubMed ID: 20574455
[TBL] [Abstract][Full Text] [Related]
33. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
35. BCR-ABL kinase is dead; long live the CML stem cell.
Perl A; Carroll M
J Clin Invest; 2011 Jan; 121(1):22-5. PubMed ID: 21157035
[TBL] [Abstract][Full Text] [Related]
36. Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.
Chomel JC; Turhan AG
Oncotarget; 2011 Sep; 2(9):713-27. PubMed ID: 21946665
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.
Zhang B; Li L; Ho Y; Li M; Marcucci G; Tong W; Bhatia R
J Clin Invest; 2016 Mar; 126(3):975-91. PubMed ID: 26878174
[TBL] [Abstract][Full Text] [Related]
38. Role of anti-apoptotic pathways activated by BCR/ABL in the resistance of chronic myeloid leukemia cells to tyrosine kinase inhibitors.
Danisz K; Blasiak J
Acta Biochim Pol; 2013; 60(4):503-14. PubMed ID: 24273759
[TBL] [Abstract][Full Text] [Related]
39. Chronic myeloid leukemia stem cells.
Houshmand M; Simonetti G; Circosta P; Gaidano V; Cignetti A; Martinelli G; Saglio G; Gale RP
Leukemia; 2019 Jul; 33(7):1543-1556. PubMed ID: 31127148
[TBL] [Abstract][Full Text] [Related]
40. Chronic myelogenous leukemia: mechanisms underlying disease progression.
Shet AS; Jahagirdar BN; Verfaillie CM
Leukemia; 2002 Aug; 16(8):1402-11. PubMed ID: 12145676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
